Table 1 Participants characteristics.
From: Grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder
Demographics and psychometrics | Mean ± SD or n (%) |
|---|---|
Sample size (n) | 51 (100%) |
Age (years) | 34.7 ± 6.0 |
BMI | 23.7 ± 3.4 |
Menarche (years) | 13 ± 2 |
Menstrual cycle length (days) | 28 ± 2 |
Nicotine users | 11 (21.6%) |
Smoking cigarettes | 6 (54.5%) |
Dipping tobacco | 6 (54.5%) |
Alcohol use (AUDIT score) | 3.35 ± 2.28 |
PMDD clinical characteristics | |
Age at onset (years) | 24 ± 7 |
Illness duration (years) | 11 ± 7 |
Total DRSP score | 70.6 ± 15.0 |
Previous PMDD treatment | 41 (80.4%) |
SSRI | 29 (70.7%) |
Hormonal treatment | 21 (51.2%) |
Homeopathy | 9 (22.0%) |
Psychological support | 4 (9.8%) |
Psychiatric history | 22 (43.1%) |
Depressive disorder | 17 (77.3%) |
Anxiety disorder | 5 (22.7%) |
Depressive and anxiety disorders | 3 (13.6%) |
Anorexia | 2 (9.1%) |
Bulimia | 2 (9.1%) |
Hormonal concentrations | |
Estradiol (pmol/L) | 389.7 ± 239.3 |
Progesterone (nmol/L) | 21.2 ± 16.1 |
